Bio-Techne (TECH) Current Deferred Tax Assets (2010 - 2015)
Bio-Techne's quarterly Current Deferred Tax Assets came in at $11.5 million in Q4 2015, down 12.05% year-on-year from $13.1 million in Q4 2014, and down 30.96% quarter-over-quarter from $16.7 million in Q3 2015.
Bio-Techne has reported Current Deferred Tax Assets for 5 years, with the latest figure at $11.5 million in Q4 2015.
- For the quarter ending Q4 2015, Current Deferred Tax Assets fell 12.05% year-over-year to $11.5 million; the trailing twelve-month figure through Dec 2015 stood at $11.5 million (down 12.05% YoY), and the FY2015 full-year result was $11.5 million, up 19.62% from the prior year.
- Current Deferred Tax Assets for Q4 2015 stood at $11.5 million, down from $16.7 million in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $19.1 million in Q3 2014, with the low at $5.8 million in Q2 2011.
- Average Current Deferred Tax Assets over 4 years is $11.2 million, with a median of $11.2 million recorded in 2011.
- Year-over-year, Current Deferred Tax Assets sank 56.67% in 2011 and jumped 100.99% in 2014.
- Tracing TECH's Current Deferred Tax Assets over 4 years: stood at $12.9 million in 2011, then declined by 23.55% to $9.9 million in 2013, then soared by 32.52% to $13.1 million in 2014, then retreated by 12.05% to $11.5 million in 2015.
- The last three Current Deferred Tax Assets figures came in at $11.5 million (Q4 2015), $16.7 million (Q3 2015), and $11.5 million (Q2 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 11.51 Mn |
| Dec 31, 2015 | 11.51 Mn |
| Sep 30, 2015 | 16.68 Mn |
| Sep 30, 2015 | 16.68 Mn |
| Jun 30, 2015 | 11.51 Mn |
| Jun 30, 2015 | 11.51 Mn |
| Mar 31, 2015 | 11.73 Mn |
| Mar 31, 2015 | 11.73 Mn |
| Dec 31, 2014 | 13.09 Mn |
| Dec 31, 2014 | 13.09 Mn |
| Sep 30, 2014 | 19.15 Mn |
| Sep 30, 2014 | 19.15 Mn |
| Jun 30, 2014 | 9.62 Mn |
| Jun 30, 2014 | 9.62 Mn |
| Mar 31, 2014 | 8.51 Mn |
| Mar 31, 2014 | 8.51 Mn |
| Dec 31, 2013 | 9.88 Mn |
| Dec 31, 2013 | 9.88 Mn |
| Sep 30, 2013 | 9.53 Mn |
| Sep 30, 2013 | 9.53 Mn |
| Dec 31, 2011 | 12.92 Mn |
| Dec 31, 2011 | 12.92 Mn |
| Sep 30, 2011 | 6.73 Mn |
| Sep 30, 2011 | 6.73 Mn |
| Jun 30, 2011 | 5.80 Mn |
| Jun 30, 2011 | 5.80 Mn |
| Mar 31, 2011 | 10.84 Mn |
| Mar 31, 2011 | 10.84 Mn |
| Dec 31, 2010 | 12.12 Mn |
| Dec 31, 2010 | 12.12 Mn |
| Sep 30, 2010 | 12.63 Mn |
| Sep 30, 2010 | 12.63 Mn |
| Jun 30, 2010 | 13.38 Mn |
| Jun 30, 2010 | 13.38 Mn |